South Korea based Seoul Viosys, is promoting new Violeds technology solution, the world’s first ultraviolet LED te...
KT Corp., South Korea's largest telecommunications company, is developing a COVID-19 infection risk assessment...
At a time when the entire world is reeling under the impact of COVID-19, members of Shincheonji Church from South Korea ...
South Korean firm LG Chem Life Sciences, a division of LG Chem, and TransThera Biosciences Co. Ltd., a clinical-stage bi...
US based Novavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious di...
South Korea based Samsung Biologics held an online press conference to announce its plans to break ground for a ...
South Korea based Celltrion Group recently announced the launch of two rapid kits for SARS-CoV-2 in the US by the third ...
Daewoong Pharmaceutical Co. Ltd., South Korea (through its subsidiary, Daewoong Pharmaceutical India Pvt. Ltd.) and Mank...
Merck, and Hanmi Pharmaceutical (Korea-based pharmaceutical company) have announced that the companies have entered in...
South Korean firm Samsung Biologics held an online ceremony to announce the launch of its proprietary cell line technolo...
Korean biotech company Macrogen has recently announced that it has obtained the CE marking for Europe's I...
South Korean firm PharmAbcine Inc. entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to ...
Korean biotech, GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for...
South Korean firm Seegene, Inc. has announced that U.S. Food and Drug Administration (FDA) has further expanded the emer...
South Korean firm Samsung Biologics has announced a plan to expand its Drug Product (DP) capability in line with increas...
South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...
South Korea based Samsung Biologics recently announced strong financial results for its fiscal 2020 second quarter endin...
CGBIO, first medical healthcare company to successfully develop an aesthetic premium filler 'Giselleligne' using the R2 ...
